What Is the Leukoplakia Recurrence Rate After Treatment?
At a Glance
Oral leukoplakia returns in about 22% of treated lesions overall, but long-term studies report rates approaching 50%. Risk depends on the lesion, treatment, and follow-up time, and any persistent or new patch should be examined because it may need a repeat biopsy.
In this answer
4 sections
Oral leukoplakia comes back after treatment in a significant number of cases. A large review of 80 studies, analyzing over 7,000 treated lesions, found an overall pooled recurrence rate of 22% after various forms of surgery [1]. However, this number is an average across many different situations.
The true likelihood of a patch returning varies widely depending on the type of lesion, the specific treatment used, and the length of follow-up. Published rates are not a personal forecast. For example, some studies tracking patients for several years report cumulative recurrence rates approaching 50% [2].
Why Recurrence Rates Vary
When looking at the research, the chances of oral leukoplakia returning are associated with several key factors, though no single factor guarantees a lesion will or won’t return:
- Time since treatment: Recurrence rates increase as time passes. One prospective study tracking patients after surgical removal found that about 45% of patients had a recurrence within four years, and 49% within five years [2]. Other smaller, shorter-term studies report recurrences between 27% and 31% over 18 to 30 months [3][4].
- Lesion appearance: The visual type of the leukoplakia is an important factor. Homogeneous lesions (flat, uniform, and entirely white) are generally less likely to return. In contrast, non-homogeneous lesions (which may have red areas, nodules, or an irregular surface) are associated with higher recurrence rates; one specific study found that 56% of non-homogeneous lesions returned after surgery [2].
- Location: Leukoplakia that spans multiple areas or is located in the retromolar region (the area in the very back of the mouth behind your last molars) is associated with higher recurrence rates in some large reviews [1].
- Treatment method: How the tissue is treated plays a role. Evidence from some observational studies suggests that complete excision results in fewer recurrences than superficial vaporization [5]. For example, a short-term study using diode lasers found a 6.7% recurrence rate for excision compared to 26.7% for ablation after six months [6]. However, treatment choice is highly individualized based on the lesion’s size, location, and the patient’s health. No technique completely eliminates the risk of recurrence [1].
| Treatment Method | How it Works | Tissue for Pathology? | Typical Considerations | Limitations |
|---|---|---|---|---|
| Excision | Cuts out the lesion entirely with a margin of healthy-looking tissue. | Yes. The entire removed tissue can be examined by a pathologist. | Often preferred for lesions with high-grade dysplasia or suspected cancer. | Requires stitches; longer healing time. Recurrence can still happen. |
| Vaporization / Ablation | Uses a laser to burn away the surface cells. | No. The tissue is destroyed during the procedure. | Often considered for larger, widespread, or lower-risk lesions to preserve normal mouth structure. | No tissue remains to confirm dysplasia grade. Recurrence can still happen. |
Is it Regrowth or a New Lesion?
If a new white patch appears after treatment, it might be a true recurrence (the original lesion growing back at the surgical site), but it could also be an entirely new lesion nearby. This happens due to a concept known as field cancerization [7].
Field cancerization means that a larger area of your oral tissue—a “field”—has been altered by risk factors like tobacco use or genetic changes, making it prone to developing abnormal cells over time [8]. Even if one specific patch is completely removed, the surrounding tissue may still develop new leukoplakia spots [7]. This does not mean cancer is spreading; rather, the tissue simply has a higher tendency to form new patches.
Additionally, there is a specific, rare subtype called proliferative verrucous leukoplakia (PVL), which is known for being persistent, progressive, and highly likely to result in multiple new lesions forming in different areas of the mouth over time [9][10].
What is Normal After Treatment?
After surgery or laser treatment, the treated area will go through a normal healing process. You may see a white or yellowish coating form over the site—this is often wet scab tissue, not a recurrence of leukoplakia. Your surgeon will tell you what this normal healing should look like and how long it should last. However, do not try to scrape or self-diagnose a new white area. If a white patch persists after the expected healing period, or if a new patch develops months later, it needs to be clinically examined by your doctor.
What Happens if a Patch Returns?
Discovering that your leukoplakia has returned can be frustrating, but recurrence does not by itself mean you have cancer or that your initial treatment failed. It does mean that reassessment by your specialist is necessary.
If a patch comes back, your care team will examine it closely, noting its size, color, and texture [11]. In most cases, a recurrent patch will need a repeat biopsy (removing a small piece of tissue for laboratory testing) [11]. You might wonder why a new biopsy is necessary if the first one was benign. There are two main reasons:
- Things change: Recurrent leukoplakia has a higher risk of transforming into cancer over time compared to lesions that never return [1][12].
- Sampling limits: An initial biopsy only tests a small piece of tissue, and it is possible for the grade of dysplasia (the degree of abnormal, pre-cancerous cell growth) to be underestimated [13]. Furthermore, a biopsy showing no dysplasia lowers your risk but does not eliminate it completely. In one large study of patients who eventually developed oral cancer, nearly 40% of those cancers arose from leukoplakia that had previously shown no dysplasia on an initial biopsy [14]. This highlights why ongoing monitoring is crucial, even when initial results are reassuring.
Based on the new biopsy results, you and your specialist (such as an oral surgeon or oral medicine specialist) will discuss the next steps. Decisions are individualized. If the new biopsy shows high-grade dysplasia, definitive treatment like repeat excision is often recommended [4]. If it shows no dysplasia or very mild changes, your doctor might recommend careful observation [15]. However, observation means planned, structured examinations, not simply doing nothing.
When to Contact Your Doctor
Long-term monitoring is essential. While some changes are part of normal healing, you should contact your treating clinician promptly—before your next scheduled appointment—if you notice:
- Rapid enlargement of a white patch
- New red areas or ulcerations (sores)
- Induration (the area feels hard or firm)
- Persistent pain, bleeding, or numbness
- A new lump in your neck, or new difficulty chewing, swallowing, or speaking
Common questions in this guide
How often does oral leukoplakia come back after treatment?
Is recurrence less likely after excision than after laser ablation?
What increases the chance that oral leukoplakia will return?
How can I tell normal healing from a recurrent white patch?
Will a returning leukoplakia patch need another biopsy?
Does recurrence mean that the patch is cancer?
What happens if a repeat biopsy shows severe abnormal cell changes?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Returning white patches
Would I need a repeat biopsy if a white patch returns after treatment?
Treatment options
Which treatment method, such as excision or vaporization, might suit my lesion?
Long-term monitoring
How often should my mouth be examined for new patches after treatment?
Related questions
Show more
Get notified when new evidence is published on oral mucosa leukoplakia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
Recurrence in Oral Leukoplakia: A Systematic Review and Meta-analysis.
Bhattarai BP, Singh AK, Singh RP, et al.
Journal of dental research 2024; (103(11)):1066-1075 doi:10.1177/00220345241266519.
PMID: 39290142 - 2
Recurrence rates after surgical removal of oral leukoplakia-A prospective longitudinal multi-centre study.
Sundberg J, Korytowska M, Holmberg E, et al.
PloS one 2019; (14(12)):e0225682 doi:10.1371/journal.pone.0225682.
PMID: 31810078 - 3
Evaluation of Clinical Outcomes and Recurrence After Surgical Excision of Oral Leukoplakia: A Prospective Cohort Study.
Talreja L, Goyal R, Yadav D, et al.
Cureus 2024; (16(10)):e71593 doi:10.7759/cureus.71593.
PMID: 39552995 - 4
Malignant transformation of oral leukoplakia: a follow-up study.
Jayasooriya PR, Dayaratne K, Dissanayake UB, Warnakulasuriya S
Clinical oral investigations 2020; (24(12)):4563-4569 doi:10.1007/s00784-020-03322-4.
PMID: 32436158 - 5
Evaluation of Different Laser-Supported Surgical Protocols for the Treatment of Oral Leukoplakia: A Long-Term Follow-Up.
Nammour S, Zeinoun T, Namour A, et al.
Photomedicine and laser surgery 2017; (35(11)):629-638 doi:10.1089/pho.2016.4256.
PMID: 28426376 - 6
Clinical Outcomes of Diode Laser Ablation Versus Diode Laser Excision in the Management of Oral Leukoplakia: An Observational Study.
Dua N, Singh N, Gupta RK, et al.
Cureus 2026; (18(7)):e113690 doi:10.7759/cureus.113690.
PMID: 42670369 - 7
Oral leukoplakia, the ongoing discussion on definition and terminology.
van der Waal I
Medicina oral, patologia oral y cirugia bucal 2015; (20(6)):e685-92 doi:10.4317/medoral.21007.
PMID: 26449439 - 8
New insights into the genetic progression of cancer through longitudinal analysis of oral lesions.
Wils LJ, Poell JB, Brink A, et al.
The Journal of pathology 2025; (267(2)):155-167 doi:10.1002/path.6449.
PMID: 40728388 - 9
Oral leukoplakia and proliferative verrucous leukoplakia: a review for dental practitioners.
Staines K, Rogers H
British dental journal 2017; (223(9)):655-661 doi:10.1038/sj.bdj.2017.881.
PMID: 29097794 - 10
Heterogeneous mechanisms, risk stratification, and translational advances in the malignant transformation of oral potentially malignant disorders to oral squamous cell carcinoma.
Yu Z, Peng H, Cheng X, et al.
Frontiers in molecular biosciences 2026; (13()):1948915 doi:10.3389/fmolb.2026.1948915.
PMID: 42828028 - 11
Clinico-Pathological Assessment and Malignant Transformation in Patients with Oral Epithelial Dysplasia - A Follow-up Cohort Study.
Yasothkumar D, Ramani P, Ramasubramanian A
Head and neck pathology 2025; (19(1)):96 doi:10.1007/s12105-025-01833-8.
PMID: 40758174 - 12
Laser excision of oral leukoplakia: Does it affect recurrence and malignant transformation? A systematic review and meta-analysis.
de Pauli Paglioni M, Migliorati CA, Schausltz Pereira Faustino I, et al.
Oral oncology 2020; (109()):104850 doi:10.1016/j.oraloncology.2020.104850.
PMID: 32540612 - 13
Diagnostic discrepancies in the surgical management of oral epithelial dysplasia - an analysis of concordance between incisional biopsy and definitive resection specimens.
Maloney B, Jung MS, Byrne J, et al.
Oral surgery, oral medicine, oral pathology and oral radiology 2026; (142(3)):362-374 doi:10.1016/j.oooo.2026.03.001.
PMID: 42020233 - 14
Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study.
Chaturvedi AK, Udaltsova N, Engels EA, et al.
Journal of the National Cancer Institute 2020; (112(10)):1047-1054 doi:10.1093/jnci/djz238.
PMID: 31860085 - 15
A Randomized Controlled Trial on Efficacy of Surgical Excision of Nondysplastic Leukoplakia to Prevent Oral Cancer.
Arduino PG, Lodi G, Cabras M, et al.
Cancer prevention research (Philadelphia, Pa.) 2021; (14(2)):275-284 doi:10.1158/1940-6207.CAPR-20-0234.
PMID: 32958584
This page is for informational purposes only and does not constitute medical advice. Your oral surgeon or oral medicine specialist should interpret your healing, biopsy results, and follow-up needs.